Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T20:48:51.206Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:48:51.206Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,837,354
Total debt · period ending 2026-06-30: N/A
Cash · period ending 2026-06-30: N/A
TTM free cash flow · period ending 2026-06-30: -19,599,000

FMP input reference: 4def03d60821895559c9c20c19e54220183163157c982acdbaf0d7b6ba02223d

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

XAIR EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

XAIR Competitors' EV/FCF Ratio

XAIR

Beyond Air, Inc.

Current

Market Cap

$1.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TNON

Tenon Medical, Inc.

vs XAIR

Market Cap

$1.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PFSA

Profusa, Inc. Common Stock

vs XAIR

Market Cap

$1.83M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TCRT

Alaunos Therapeutics, Inc.

vs XAIR

Market Cap

$1.81M

EV/FCF Ratio

N/A

TTM Avg

69.66x

3Y Avg

69.66x

5Y Avg

69.66x

RNAZ

TransCode Therapeutics, Inc.

vs XAIR

Market Cap

$1.88M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs XAIR

Market Cap

$1.88M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SILO

Silo Pharma, Inc.

vs XAIR

Market Cap

$1.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs XAIR

Market Cap

$2.13M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VVOS

Vivos Therapeutics, Inc.

vs XAIR

Market Cap

$2.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs XAIR

Market Cap

$1.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Beyond Air, Inc. (XAIR)	$1.84M	N/A	N/A	N/A	N/A
Tenon Medical, Inc. (TNON)vs ›	$1.84M	N/A	N/A	N/A	N/A
Profusa, Inc. Common Stock (PFSA)vs ›	$1.83M	N/A	N/A	N/A	N/A
Alaunos Therapeutics, Inc. (TCRT)vs ›	$1.81M	N/A	69.66x	69.66x	69.66x
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.88M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.88M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.64M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.13M	N/A	N/A	N/A	N/A
Vivos Therapeutics, Inc. (VVOS)vs ›	$2.14M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.52M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

XAIR EV/FCF Ratio History

DATE	EV/FCF RATIO
2019-11-06	76.88x
2019-11-05	81.37x
2019-11-04	81.14x
2019-11-01	82.88x
2019-10-31	82.69x
2019-10-30	84.14x
2019-10-29	85.59x
2019-10-28	86.56x
2019-10-25	90.43x
2019-10-24	84.62x
2019-10-23	85.98x
2019-10-22	80.17x
2019-10-21	85.98x
2019-10-18	86.17x
2019-10-17	86.56x
2019-10-16	86.17x
2019-10-15	83.85x
2019-10-14	80.98x
2019-10-11	86.36x
2019-10-10	90.50x
2019-10-09	84.05x
2019-10-08	85.40x
2019-10-07	86.93x
2019-10-04	86.93x
2019-10-03	87.91x
2019-10-02	87.91x
2019-10-01	89.27x
2019-09-30	88.51x
2019-09-27	90.04x
2019-09-26	83.07x
2019-09-25	80.17x
2019-09-24	86.17x
2019-09-23	87.91x
2019-09-20	94.88x
2019-09-19	90.04x
2019-09-18	90.43x
2019-09-17	93.45x
2019-09-16	93.91x
2019-09-13	95.07x
2019-09-12	95.26x
2019-09-11	95.26x
2019-09-10	94.30x
2019-09-09	94.88x
2019-09-06	94.68x
2019-09-05	94.30x
2019-09-04	96.04x
2019-09-03	92.94x
2019-08-30	95.26x
2019-08-29	95.46x
2019-08-28	94.30x
2019-08-27	96.04x
2019-08-26	95.85x
2019-08-23	96.23x
2019-08-22	95.65x
2019-08-21	95.26x
2019-08-20	97.78x
2019-08-19	96.81x
2019-08-16	98.64x
2019-08-15	100.88x
2019-08-14	39.88x
2019-08-13	39.59x
2019-08-12	39.34x
2019-08-09	39.59x
2019-08-08	38.27x
2019-08-07	39.83x
2019-08-06	40.28x
2019-08-05	38.14x
2019-08-02	39.18x
2019-08-01	40.09x
2019-07-31	39.42x
2019-07-30	40.71x
2019-07-29	40.79x
2019-07-26	41.19x
2019-07-25	40.23x
2019-07-24	40.39x
2019-07-23	42.00x
2019-07-22	41.19x
2019-07-19	42.16x
2019-07-18	42.40x
2019-07-17	42.32x
2019-07-16	46.25x
2019-07-15	44.80x
2019-07-12	41.11x
2019-07-11	40.15x
2019-07-10	41.11x
2019-07-09	38.38x
2019-07-08	35.97x
2019-07-05	43.10x
2019-07-03	43.44x
2019-07-02	43.44x
2019-07-01	43.04x
2019-06-28	43.60x

EV/FCF Ratio: N/A

XAIR EV/FCF Ratio Chart

XAIR EV/FCF Ratio Metrics

XAIR Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

XAIR EV/FCF Ratio History

Related Metrics